As MCs in SM can produce both RANKL and OPG, OPG and RANKL levels are elevated in patients with mastocytosis, which implies that the RANKL/RANK/OPG pathway is involved in bone changes associated with the disease [44,47]. The gene discussed is TNFRSF11B; the disease is mastocytosis.